More about
Combination Drug Therapy
News
July 24, 2020
2 min read
Save
CheckMate-214: Combination therapy is the new ‘standard of care’ in RCC
The release of findings from the Checkmate-214 study produced multiple changes for specialists in renal cell carcinoma. Chung-Han Lee, MD, PhD, medical oncologist at Memorial Sloan Kettering Cancer Center, spoke with Healio about CheckMate-214 findings, clinical relevance, FDA approvals of TKI/IO regimens and possible novel agents.
News
June 18, 2020
1 min read
Save
Combination ophthalmic suspension for glaucoma launches in Japan
News
December 30, 2019
2 min read
Save